Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma
- 16 October 2006
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 135 (4), 513-516
- https://doi.org/10.1111/j.1365-2141.2006.06331.x
Abstract
Present therapies cannot cure the large majority of patients with multiple myeloma (MM) and therefore new treatment strategies are imperative. This study analysed the different glycosylation profiles of Mucin-1 (MUC1) on MM and acute myeloid leukaemia (AML) cells using a series of anti-MUC1 antibodies. Seventy-three per cent of the MM patients had plasma cells that expressed the fully glycosylated forms of MUC1. In contrast to controls, normal bone marrow cells and AML cells, the differentiation-dependent and cancer-associated glycoforms of MUC1 were present on 59% and 36% MM tumour cells respectively. This indicated that aberrantly glycosylated MUC1 is a potential immunotherapeutic target in MM patients.Keywords
This publication has 9 references indexed in Scilit:
- Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vectorCytotherapy, 2006
- Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override toleranceGlycobiology, 2005
- Expression of CD52 on plasma cells in plasma cell proliferative disordersBlood, 2003
- CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic ApplicationsJournal of Immunotherapy, 2002
- Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by DexamethasoneBlood, 1999
- Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.International Immunology, 1997
- Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigenBritish Journal of Haematology, 1997
- Detection of myeloma cells in the peripheral blood by flow cytometryCytometry, 1996
- Exploiting altered glycosylation patterns in cancer: Progress and challenges in diagnosis and therapyTrends in Biotechnology, 1994